Quadrivalent Meningitis (MCV4)
4.9 (694) · € 61.50 · En Stock
Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study - The Lancet Infectious Diseases
Importance of Meningococcal Disease and Its Prevention David R. Johnson, MD, MPH Vice President and Regional Medical Expert Sanofi Pasteur Medical Affairs. - ppt download
Global Meningococcal Vaccine Market- Growth, Trends, Covid-19 Impact & Forecast
Meningococcal Vaccine Toolkit
Meningococcal conjugate vaccines
Full article: Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy
Haemophilus Influenzae Type B Meningococcus Tetanus Vaccine - an overview
Meningococcal Vaccine Toolkit
Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older
Menactra 4Mcg 0.5ml, Usage: Hospital at Rs 4950/pack in Chennai
